NEW YORK (Nov. 28, 2023)—Weill Cornell Medicine is dramatically expanding its campus and research footprint in New York City by securing five floors of 1334 York Ave., the current home of Sotheby's auction house, the institution announced today.
Bishoy M. Faltas Receives Prestigious MERIT Grant
November 21, 2023
Dr. Bishoy M. Faltas, director of bladder cancer research at the Englander Institute for Precision Medicine at Weill Cornell Medicine, the Gellert Family-John P. Leonard, M.D. Research Scholar and an assistant professor of medicine at Weill Cornell Medicine has been awarded a $4 million, seven-year MERIT grant from the National Cancer Institute (NCI) at the National Institutes of Health (NIH).
EIPM Researcher Elected to National Academy of Medicine
October 9, 2023
Dr. Lisa Newman, chief of the section of breast surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and Dr. Jedd D.
EIPM's 3Q External Newsletter
October 6, 2023
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our third quarterly external newsletter of 2023!
Department of Defense Grant Awarded to Study Metastasis in Bladder Cancer
October 4, 2023
A Weill Cornell Medicine researcher has received a $610,000 grant from the Department of Defense to investigate the mechanisms causing DNA instability that potentially drives metastasis in bladder cancer. The research also aims to identify methods to intercept this spread. The Peer-Reviewed Cancer Research Program (PRCRP) Idea Award funds innovative, high-risk, high-reward basic cancer research.
October 2023 EIPM Director's Memo
October 2, 2023
Dear Members of the Englander Institute,
Thank you all so much for a very successful and productive September!
I'm thrilled to share that the Englander Institute for Precision Medicine will host the 20th International Cancer Genome Consortium Scientific Workshopfrom November 7-9. The program is still coming together and we hope to share additional information with you soon.
September 2023 EIPM Director's Memo
September 7, 2023
Dear Members of the Englander Institute,
Thank you all so much for another very successful and productive month!
National Organization for Rare Disorders Designates Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center as a Rare Disease Center of Excellence
September 7, 2023
Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center have together been named a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). The designation adds the academic medical center to NORD’s collaborative network of 40 participating institutions that research and treat rare diseases.
A New Targeted Treatment Shows Promise for Select Patients with Stomach Cancer
August 23, 2023
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for patients with advanced gastric or gastroesophageal junction cancer that overexpressed a specific biomarker.